Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Coenzyme Q10 effects in neurodegenerative disease.

Spindler M, Beal MF, Henchcliffe C.

Neuropsychiatr Dis Treat. 2009;5:597-610. Epub 2009 Nov 16.

2.

Coenzyme Q10 and Neurological Diseases.

Mancuso M, Orsucci D, Calsolaro V, Choub A, Siciliano G.

Pharmaceuticals (Basel). 2009 Dec 1;2(3):134-149. Review.

3.

Coenzyme Q10 in neuromuscular and neurodegenerative disorders.

Mancuso M, Orsucci D, Volpi L, Calsolaro V, Siciliano G.

Curr Drug Targets. 2010 Jan;11(1):111-21. Review.

PMID:
20017723
4.

Mitochondrial diseases of the brain.

Chaturvedi RK, Flint Beal M.

Free Radic Biol Med. 2013 Oct;63:1-29. doi: 10.1016/j.freeradbiomed.2013.03.018. Epub 2013 Apr 6. Review.

PMID:
23567191
5.
6.

Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.

Yang X, Zhang Y, Xu H, Luo X, Yu J, Liu J, Chang RC.

Curr Top Med Chem. 2016;16(8):858-66. Review.

PMID:
26311425
7.

Coenzyme Q10 as a possible treatment for neurodegenerative diseases.

Beal MF.

Free Radic Res. 2002 Apr;36(4):455-60. Review.

PMID:
12069110
8.

Coenzyme Q treatment of neurodegenerative diseases of aging.

Galpern WR, Cudkowicz ME.

Mitochondrion. 2007 Jun;7 Suppl:S146-53. Epub 2007 Mar 27. Review.

PMID:
17485247
9.

Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.

Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA.

J Neurol Sci. 2005 Jun 15;233(1-2):145-62. Review.

PMID:
15896810
10.
11.

Coenzyme Q10: a review of its promise as a neuroprotectant.

Young AJ, Johnson S, Steffens DC, Doraiswamy PM.

CNS Spectr. 2007 Jan;12(1):62-8. Review.

PMID:
17192765
12.

Dose ranging and efficacy study of high-dose coenzyme Q10 formulations in Huntington's disease mice.

Smith KM, Matson S, Matson WR, Cormier K, Del Signore SJ, Hagerty SW, Stack EC, Ryu H, Ferrante RJ.

Biochim Biophys Acta. 2006 Jun;1762(6):616-26. Epub 2006 Apr 17.

13.

Mitochondria, NO and neurodegeneration.

Beal MF.

Biochem Soc Symp. 1999;66:43-54. Review.

PMID:
10989656
14.

[Coenzyme Q10 in Parkinson's disease. Symptomatic or neuroprotective effects?].

Storch A.

Nervenarzt. 2007 Dec;78(12):1378-82. Review. German.

PMID:
17508194
15.

Mitochondrial approaches for neuroprotection.

Chaturvedi RK, Beal MF.

Ann N Y Acad Sci. 2008 Dec;1147:395-412. doi: 10.1196/annals.1427.027. Review.

16.

Coenzyme Q10 in neurodegenerative diseases.

Shults CW.

Curr Med Chem. 2003 Oct;10(19):1917-21. Review.

PMID:
12871093
17.

Effect of Coenzyme Q10 supplementation on mitochondrial electron transport chain activity and mitochondrial oxidative stress in Coenzyme Q10 deficient human neuronal cells.

Duberley KE, Heales SJ, Abramov AY, Chalasani A, Land JM, Rahman S, Hargreaves IP.

Int J Biochem Cell Biol. 2014 May;50:60-3. doi: 10.1016/j.biocel.2014.02.003. Epub 2014 Feb 15.

PMID:
24534273
18.

Coenzyme q10 therapy.

Garrido-Maraver J, Cordero MD, Oropesa-Ávila M, Fernández Vega A, de la Mata M, Delgado Pavón A, de Miguel M, Pérez Calero C, Villanueva Paz M, Cotán D, Sánchez-Alcázar JA.

Mol Syndromol. 2014 Jul;5(3-4):187-97. doi: 10.1159/000360101.

19.

Co-enzyme Q10 to treat neurological disorders: basic mechanisms, clinical outcomes, and future research direction.

Salama M, Yuan TF, Machado S, Murillo-Rodríguez E, Vega JA, Menéndez-González M, Nardi AE, Arias-Carrión O.

CNS Neurol Disord Drug Targets. 2013 Aug;12(5):641-64. Review.

PMID:
23574157
20.

Neuroprotective effects of creatine.

Beal MF.

Amino Acids. 2011 May;40(5):1305-13. doi: 10.1007/s00726-011-0851-0. Epub 2011 Mar 30. Review.

PMID:
21448659

Supplemental Content

Support Center